Loading...
Library search
Pharmaceutical Marketing and Transparency in Japan
Japan is a promising market for companies, in-spite of the pressures posed by drug prices, competition and patents. The reason may be the large growth of pharmaceuticals, an aging population,...Read more
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA
Digital Media in the Pharmaceutical Industry: Oportunities and Legal Challenges
The term digital media is widely understood. According to the open-access encyclopedia Wikipedia digital media shall mean a “form of electronic media where data are stored in digital (as opposed...Read more

Marc Bauer
Legal Director, AMGEN (Europe) GmbH, Switzerland
A Patent Sea Change: The First Serving of Major Global Patent Law Changes Begins
This decade brings a sea change in patent law, with significant changes to the patent systems of Europe, the United States and Australia as well as a rapidly maturing Chinese...Read more
Jason Garbell
Senior Patent Counsel, Novozymes AS, Denmark
Self-Regulation of an Industry versus the Rule of Law
Self-regulation is an honourable concept. Proponents of the system emphasise the relative amiability and expediency of dispute resolution mechanisms, and remind industry that to the extent that it is not...Read more
Howard Snoyman
Head: Legal and Ethics, Discovery Health Medical Scheme, South Africa
Canadian Risky Business: Why Fair and Predictable Patentable Utility is Critical to Investments and Innovation
Investment in innovation and procurement of patent protection within any jurisdiction is justified by reliance upon fair and predictable patent protection. For new investment within any particular jurisdiction, innovators expect...Read more
Arvie Anderson
Assistant General Patent Counsel, Eli Lilly and Company, USA
R&D Based Pharmaceutical Companies Vs. Generic Companies: A False Dichotomy?
As recently as a decade ago, there was a clear line separating R&D-based pharmaceutical companies and generic companies; on one side were innovator pharmaceutical companies focused on developing innovative new...Read more

Sharon Reiche
Corporate Counsel, Intellectual Property Policy, Pfizer Inc, USA
Data Protection in the Pharmaceutical Industry: Concerns and Considerations
Data protection is an important aspect of the pharmaceutical industry throughout all stages of a product lifecycle – from innovation to exit. In the early stages of product development, manufacturers...Read more
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
Pharmaceutical Patent Protection in Turkey
Between 1994 and 1995, Turkey conducted necessary legislative studies to establish an efficient and contemporary industrial property system and obtained very important concrete results. Turkey has ratified many international agreements...Read more

Gaye Ramazanoglu Partlak
Intellectual Property Specialist, Sanovel Ilac San.ve Tic. A.S., Turkey
Pharmaceutical Ethic Codes: How to draft a Pharmaceutical Ethic Codes without inhibiting your business
Pharmaceutical Industry is very risky business, not only that the company needs to grow its profit but it must show to the people that they contribute to the human health...Read more

Tri Junanto Wicaksono
Head of GA & Legal, PT. Amerta Indah Otsuka, Indonesia
Doing Business in Brazil
The entry of Brazil into the Emerging Markets Group, leading the Latin America economy, increased the number of players interested in the Brazilian pharmaceutical market. Brazilian Legislation has been in...Read more
Fátima Picôto
Legal Director Brazil, Glaxosmithkline Brasila, Brazil